Nephropathy News and Research

RSS

Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete any waste products and to regulate the water and acid-base balance of the body – therefore loss of kidney function is a potentially fatal condition.

1 in 5 youth with diabetes has heart risk

With the epidemic of obesity in the United States leading to a greater incidence of diabetes among youth, a new study highlights why Americans cannot afford to ignore this dangerous trend: One in five youth with diabetes has already developed two or more additional risk factors for premature heart disease.

27 Jul 2006

Increasing rates of diabetes among U.S. adults

Adults in the United States have increasingly become overweight or obese in recent years, according to a national survey conducted for Indiana University, dispelling the notion of a plateau and injecting a note of urgency into efforts to help Americans achieve a healthier weight.

26 Jul 2006

Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease

Researchers have unexpectedly shown that sickle cell-associated kidney injury may be reduced by inhibiting the enzyme activity of a protein that commonly confers protection in other diseased states.

19 Jul 2006

Children with eczema have the same impaired quality of life as those with kidney disease

Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.

18 Jul 2006

Watch out for Tuna from Latin America says environment group

An environmental watchdog group say they have found that some canned tuna imported into the United States has mercury levels higher than the federal limit.

12 Jul 2006

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006

NYC's first 3-way kidney transplant

Six surgical transplant teams, including 40 clinicians, working simultaneously in six operating rooms successfully performed New York City's first three-way kidney transplant at NewYork-Presbyterian Hospital/Columbia.

26 Jun 2006

Endoscopic treatment with polydimethylsiloxane in children with dilating vesico-ureteric reflux

This group from Italy assessed their endoscopic treatment of dilating vesico-ureteric reflux (VUR) in children with polydimethylsiloxane (MacroplastiqueTM, MPQ; Uroplasty BV, Geleen, The Netherlands).

14 Jun 2006

New diabetic drugs could change the future for sufferers

According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.

13 Jun 2006

When it comes to diabetes doctors failing to follow 'doctors orders'

According to the latest reports when it comes to diabetes and following doctors orders, doctors are failing their patients.

12 Jun 2006

Popular hypertension drugs triple the risk of birth defects

A study by American researchers has found that certain widely used hypertension drugs, once considered safe in the early stages of pregnancy, can almost triple the risk of birth defects.

8 Jun 2006

Factors influencing the route of administration for Epoetin treatment among hemodialysis patients in the U.S.

A forthcoming article to be published in the July 2006 issue of the American Journal of Kidney Diseases finds that physician decision-making for the delivery of epoetin therapy is primarily influenced by the type of ownership and financial incentives associated with dialysis centers.

6 Jun 2006